Using quantitative PCR, we further show the GCNT1 gene is 1.8-fold upregulated in prostate cancer tissue relative to benign prostate hyperplasia in an additional patient cohort (n = 20, p = 0.0248) (Fig. 1B). This evidence concerns the gene GCNT1 and benign prostatic hyperplasia.